FDA Inspection 1220868 — Generitech Corporation

Generitech Corporation — FEI 3002994577

The FDA completed an inspection of Generitech Corporation on September 29, 2023 in Fresno, CA. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). Product area: Drugs.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
September 29, 2023
Fiscal Year
2023
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Fresno, CA (United States)